SynBiotic SE (SBX.DE)

EUR 3.52

(-1.4%)

Total Liabilities Summary of SynBiotic SE

  • SynBiotic SE's latest annual total liabilities in 2023 was 19.59 Million EUR , up 9.85% from previous year.
  • SynBiotic SE's latest quarterly total liabilities in 2023 FY was 19.59 Million EUR , up 9.85% from previous quarter.
  • SynBiotic SE reported annual total liabilities of 17.83 Million EUR in 2022, down -25.45% from previous year.
  • SynBiotic SE reported annual total liabilities of 23.92 Million EUR in 2021, up 151.01% from previous year.
  • SynBiotic SE reported quarterly total liabilities of - EUR for 2023 Q2, down -100.0% from previous quarter.
  • SynBiotic SE reported quarterly total liabilities of 17.83 Million EUR for 2022 Q4, up 535.04% from previous quarter.

Annual Total Liabilities Chart of SynBiotic SE (2023 - 2018)

Historical Annual Total Liabilities of SynBiotic SE (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 19.59 Million EUR 9.85%
2022 17.83 Million EUR -25.45%
2021 23.92 Million EUR 151.01%
2020 9.53 Million EUR 381114.48%
2019 2500.00 EUR 0.0%
2018 - EUR 0.0%

Peer Total Liabilities Comparison of SynBiotic SE

Name Total Liabilities Total Liabilities Difference
MPH Health Care AG 15.38 Million EUR -27.326%
Apontis Pharma AG 27.2 Million EUR 27.974%
Dermapharm Holding SE 1.62 Billion EUR 98.796%
Evotec SE 1.17 Billion EUR 98.339%
MERCK Kommanditgesellschaft auf Aktien 22.36 Billion EUR 99.912%
PharmaSGP Holding SE 91.54 Million EUR 78.6%